Medicamen Organics Limited (NSE:MEDIORG)
India · Delayed Price · Currency is INR 34.20
-1.80 (-5.00%)
At close: Sep 8, 2025
Medicamen Organics Revenue
In the fiscal year ending March 31, 2025, Medicamen Organics had annual revenue of 381.88M INR with 51.11% growth. Medicamen Organics had revenue of 213.31M in the half year ending March 31, 2025.
Revenue
381.88M
Revenue Growth
+51.11%
P/S Ratio
1.01
Revenue / Employee
3.35M
Employees
62
Market Cap
386.10M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 381.88M | 129.16M | 51.11% |
| Mar 31, 2024 | 252.72M | 31.25M | 14.11% |
| Mar 31, 2023 | 221.47M | 11.72M | 5.59% |
| Mar 31, 2022 | 209.75M | -40.72M | -16.26% |
| Mar 31, 2021 | 250.47M | -64.39M | -20.45% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,765.41B |
| HDFC Bank | 2,736.06B |
| Bharti Airtel | 1,839.41B |
| Tata Consultancy Services | 2,561.48B |
| ICICI Bank | 2,054.85B |
| State Bank of India | 3,503.84B |
| Infosys | 1,672.76B |
| Hindustan Unilever | 639.28B |